Jana Halámková

Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up†

Paolo Bossi, Anthony T.�C. Chan, Lisa Licitra et al. · Annals of Oncology · 2020 · 404 citations · Full text

Esophageal Cancer, Medicine, Cancer Management +7

MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9

Petra Vychytilova‐Faltejskova, Jana Merhautová, Táňa Macháčková et al. · Oncogenesis · 2017 · 101 citations · Full text

Medicine, Egfr Ligand Epiregulin, Pathology +13

Second primary malignancies in colorectal cancer patients

Jana Halámková, Tomáš Kazda, Lucie Pehalová et al. · Scientific Reports · 2021 · 42 citations · Full text

European Reference Network for rare adult solid cancers, statement and integration to health care systems of member states: a position paper of the ERN EURACAN

Jean‐Yves Blay, Paolo G. Casali, Corinne Bouvier et al. · ESMO Open · 2021 · 33 citations · Full text

Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients

Jana Halámková, Igor Kišš, Zdeněk Pavlovský et al. · Neoplasma · 2011 · 29 citations

Urology, Genitourinary Cancer, Urokinase Inhibitors +14